Cullinan Therapeutics, Inc.CGEMNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank86
5Y CAGR+5.0%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+5.0%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$79000.00-74.2%
2024$306000.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$62000.00-11.4%
2019$70000.00+62.8%
2018$43000.00-